Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats
- PMID: 9706795
- DOI: 10.1016/s0168-1605(98)00055-5
Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats
Abstract
In a controlled and randomised double-blind study, 26 healthy adult volunteers consumed, for 21 d, 400 ml of a rose-hip drink containing oats (0.7 g/100ml) fermented with Lactobacillus plantarum DSM 9843 (RHL; containing 5 x 10(7) cfu ml(-1)), and 22 volunteers in a second group the same amount of a pure rose-hip drink (RH). Significant increases in the total faecal concentration of carboxylic acids (P < 0.05 after 1 week and P < 0.01 after 3 weeks of intake), acetic acid (P < 0.01 after 3 weeks of intake) and propionic acid (P < 0.01 after 3 weeks of intake and P < 0.05 eight days after intake ceased) were recorded in the RHL group, indicating increased fermentation in the colon. In both groups a significant increase was obtained in the concentration of faecal lactic acid (P < 0.001 after 1 and 3 weeks of intake). No changes were seen in the concentration of faecal butyrate. The numbers of faecal bifidobacteria and lactobacilli increased significantly in both groups after 3 weeks of intake. Sulphite-reducing clostridia rapidly decreased in the group receiving the product with Lb. plantarum DSM 9843 after 1 week of intake, and then also in the pure rose-hip group after 3 weeks of intake. No changes were seen in the numbers of total anaerobes, gram-negative anaerobes or total aerobes during administration. Lb. plantarum DSM 9843 was recovered in faeces from all volunteers in the RHL group. Median amounts were 7.0 (5.0-8.8) log10 cfu g(-1) after one week of intake, and 6.7 (5.0-8.9) log10 cfu g(-1) after 3 weeks, respectively. The strain was still recovered from faeces of five volunteers 8 d after administration ceased (> 4.8 log10 cfu g(-1)). During the period of intake the volunteers in the RHL group experienced a significant increase in stool volume, a significant decrease in flatulence and slightly softer stools. Volunteers in the RH group experienced a slight but significant decrease in stool volume.
Similar articles
-
The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects.Aliment Pharmacol Ther. 2003 Sep 1;18(5):495-505. doi: 10.1046/j.1365-2036.2003.01708.x. Aliment Pharmacol Ther. 2003. PMID: 12950422 Clinical Trial.
-
Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition.Dig Liver Dis. 2005 Jan;37(1):44-50. doi: 10.1016/j.dld.2004.07.018. Dig Liver Dis. 2005. PMID: 15702859
-
The effect of a probiotic drink with Lactobacillus plantarum 299v on the bacterial composition in faeces and mucosal biopsies of rectum and ascending colon.Aliment Pharmacol Ther. 2006 Jan 15;23(2):255-63. doi: 10.1111/j.1365-2036.2006.02749.x. Aliment Pharmacol Ther. 2006. PMID: 16393305 Clinical Trial.
-
Probiotics in foods not containing milk or milk constituents, with special reference to Lactobacillus plantarum 299v.Am J Clin Nutr. 2001 Feb;73(2 Suppl):380S-385S. doi: 10.1093/ajcn/73.2.380s. Am J Clin Nutr. 2001. PMID: 11157345 Review.
-
Enteral feeding: the effect on faecal output, the faecal microflora and SCFA concentrations.Proc Nutr Soc. 2004 Feb;63(1):105-13. doi: 10.1079/pns2003317. Proc Nutr Soc. 2004. PMID: 15099408 Review.
Cited by
-
Lactobacillus plantarum 299v does not reduce enteric bacteria or bacterial translocation in patients undergoing colon resection.Dig Dis Sci. 2012 Jul;57(7):1915-24. doi: 10.1007/s10620-012-2102-y. Epub 2012 Mar 21. Dig Dis Sci. 2012. PMID: 22434095 Clinical Trial.
-
Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans.Appl Environ Microbiol. 1999 Nov;65(11):4949-56. doi: 10.1128/AEM.65.11.4949-4956.1999. Appl Environ Microbiol. 1999. PMID: 10543808 Free PMC article. Clinical Trial.
-
Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.World J Gastroenterol. 2012 Aug 14;18(30):4012-8. doi: 10.3748/wjg.v18.i30.4012. World J Gastroenterol. 2012. PMID: 22912552 Free PMC article. Clinical Trial.
-
Probiotics in the Treatment of Diarrheal Diseases.Curr Infect Dis Rep. 2000 Feb;2(1):78. doi: 10.1007/s11908-000-0092-y. Curr Infect Dis Rep. 2000. PMID: 11095842
-
Probiotics in the Management of Mental and Gastrointestinal Post-COVID Symptomes.J Clin Med. 2022 Aug 31;11(17):5155. doi: 10.3390/jcm11175155. J Clin Med. 2022. PMID: 36079082 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical